Printer Friendly
The Free Library
19,125,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Milestone Scientific Receives Notice of Allowance for Safety Infusion Device.


Business Editors/Health/Medical Writers

LIVINGSTON, N.J.--(BUSINESS WIRE)--Jan. 7, 2004

Milestone Scientific Inc. (AMEX AMEX

See: American Stock Exchange
:MS) today announced that the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  Patent Office has granted a Notice of Allowance for broad patent protection on a safety intravenous catheter introduction device. Catheter introducers are widely used in hospitals, ambulatory care centers ambulatory care center Walk-in clinic Medical practice A free-standing facility that provides non-emergent medical, or less commonly, dental services  as well in emergency medicine. This new technology provides an alternative to existing devices for the introduction of catheters that incorporates engineered sharps injury protection features which may aid in the reduction of accidental needlesticks as defined in the Federal Needlestick Safety Act.

Invented by Dr. Mark N. Hochman, Director of Clinical Affairs for Milestone Scientific, this new technology allows practitioners access to veins using a product that can be controlled with a single hand. The introducing needle and flexible catheter can be protracted pro·tract  
tr.v. pro·tract·ed, pro·tract·ing, pro·tracts
1. To draw out or lengthen in time; prolong: disputants who needlessly protracted the negotiations.

2.
 for use and retracted re·tract  
v. re·tract·ed, re·tract·ing, re·tracts

v.tr.
1. To take back; disavow: refused to retract the statement.

2.
 while not in use. The needle remains retracted until the practitioner protracts it again, allowing multiple attempts to introduce the catheter. The new device, unlike competing devices now on the market, can be used multiple times on the same patient following the failure of a catheter to be properly placed due to patient movement, collapsed veins or other causes.

A registration statement relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 Milestone's common stock and warrants has been filed with the Securities and Exchange Commission but has not become effective. The securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer and sale would be unlawful prior to registration or qualification under the securities laws of any such state. A copy of the prospectus relating to the offering may be obtained by contacting Paulson Investment Company, Inc., S.W. 811 Naito Parkway, Suite 200, Portland, OR 97204, telephone no. 503-243-6000.

Milestone Scientific is the developer, manufacturer and marketer of CompuMed(R) and CompuDent(R) computer controlled local anesthetic local anesthetic
n.
An agent that, when applied directly to mucous membranes or when injected about the nerves, produces loss of sensation by inhibiting nerve excitation or conduction.
 delivery systems. These systems comprise a microprocessor controlled drive unit as well as The Wand(R) handpiece, a single patient use product that is held in a pen like manner for injections. In 2001, Milestone Scientific received broad United States patent protection on an enabling technology for computer controlled, pressure sensitive infusion, perfusion perfusion /per·fu·sion/ (-zhun)
1. the act of pouring over or through, especially the passage of a fluid through the vessels of a specific organ.

2. a liquid poured over or through an organ or tissue.
, suffusion suffusion /suf·fu·sion/ (su-fu´zhun)
1. the process of overspreading, or diffusion.

2. the condition of being moistened or of being permeated through, as by blood.
 and aspiration, which provides real time displays of pressures, fluid densities and flow rates, that advances the delivery and removal of a wide array of fluids. In 2002, Milestone Scientific received United States patent protection on a safety engineered sharps technology, which allows for fully automated true single-handed activation with needle anti-deflection and force-reduction capability. In 2003, Milestone received FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 Clearance to market SafetyWand(TM), which incorporates engineered sharps injury protection features to aid in the prevention of accidental needlesticks.

This release contains "forward looking statements" based on current expectations but involving known and unknown risks and uncertainties. Actual results or achievements may be materially different from those expressed or implied. The Company's plans and objectives are based on assumptions involving judgments with respect to future economic, competitive and market conditions, and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Therefore, there can be no assurance that the forward-looking statements, including, but not limited to, those relating to the availability of capital pursuant to this facility, will prove to be accurate.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 7, 2004
Words:589
Previous Article:ICM Telecommunications Enters Into New Funding Agreements with Digital Communication Services and The Duncan Group to Accelerate Growth Plans.
Next Article:Empire Research Sees MYRG Target Price of $1.00 in 2004; 'MYRG is Poised to Grow into Capacity - and into Black Ink'.
Topics:



Related Articles
Milestone Scientific Inc. Adjournment of Annual Meeting of Stockholders.
Milestone Scientific Receives Notice of Allowance for New Safety Engineered Needle Technology.
Milestone Scientific Inc. Announces First Quarter Results; Reduced Losses.
Milestone Scientific, Inc. Announces Consolidation of Facilities.
Milestone Scientific Receives Notice of Allowance for Automated Rate Control Technology.
Milestone Scientific, Inc. Announces Second Quarter Financial Results.
Milestone Scientific Inc. Announces FDA Clearance of Safety Device.
Milestone Scientific Announces Closing of $9.4 Million Public Offering.
Milestone Scientific, Inc. Announces Year End Results, Improved Financial Position and Reduced Losses.
Anti-Cancer Agent Avastin(R) Approved in Japan.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles